Radioactive phospholipid metal chelates for cancer imaging and therapy
AssigneeWisconsin Alumni Research Foundation
InventorsJamey Weichert, Anatoly Pinchuk, Reinier Hernandez
Life of this patent
Estimating the term…
Loading patent…
AssigneeWisconsin Alumni Research Foundation
InventorsJamey Weichert, Anatoly Pinchuk, Reinier Hernandez
Estimating the term…
Alkylphosphocholine analogs incorporating a chelating moiety that chelates a radioactive metal isotope are disclosed herein. The alkylphophocholine analogs, which can be used to treat or detect solid tumors, have the formula: R1 includes a chelating agent that is chelated to a metal atom, wherein the metal atom is a positron or single photon emitting metal isotope with a half life of greater than or equal to 4 hours, or an alpha, beta or Auger emitting metal isotope with a half life of greater than 6 hours and less than 30 days; a is 0 or 1; n is an integer from 12 to 30; m is 0 or 1; Y is —H, —OH, —COOH, —COOX, —OCOX, or —OX, wherein X is an alkyl or an arylalkyl; R2 is —N+H3, —N+H2Z, —N+HZ2, or —N+Z3, wherein each Z is independently an alkyl or an aroalkyl; and b is 1 or 2.
A compound having the formula:
-18. (canceled)
-26. (canceled)
-33. (canceled)
(canceled)
-39. (canceled)
-44. (canceled)
(canceled)
Dependencies are inferred from the claim text.